Literature DB >> 21160034

Abnormal fibrillin-1 expression and chronic oxidative stress mediate endothelial mesenchymal transition in a murine model of systemic sclerosis.

Hao Xu1, Maria Zaidi, Janine Struve, Deron W Jones, John G Krolikowski, Sandhya Nandedkar, Nicole L Lohr, Ashish Gadicherla, Paul S Pagel, Mary Ellen Csuka, Kirkwood A Pritchard, Dorothée Weihrauch.   

Abstract

Systemic sclerosis (SSc) is an autoimmune connective tissue disorder characterized by oxidative stress, impaired vascular function, and attenuated angiogenesis. The tight-skin (Tsk(-/+)) mouse is a model of SSc that displays many of the cellular features of the clinical disease. We tested the hypotheses that abnormal fibrillin-1 expression and chronic phospholipid oxidation occur in Tsk(-/+) mice and, furthermore, that these factors precipitate a prooxidant state, collagen-related protein expression, apoptosis, and mesenchymal transition in endothelial cells cultured on Tsk(-/+) extracellular matrix. Human umbilical vein endothelial cells were seeded on microfibrils isolated from skin of C57BL/6J (control) and Tsk(-/+) mice in the presence or absence of chronic pretreatment with the apolipoprotein Apo A-I mimetic D-4F (1 mg·kg(-1)·day(-1) ip for 6 to 8 wk). Nitric oxide-to-superoxide anion ratio was assessed 12 h after culture, and cell proliferation, apoptosis, and phenotype were studied 72 h after culture. Tsk(-/+) mice demonstrated abnormal "big fibrillin" expression (405 kDa) by Western blot analysis compared with control. Endothelial cells cultured on microfibrils prepared from Tsk(-/+) mice demonstrated reduced proliferation, a prooxidant state (reduced nitric oxide-to-superoxide anion ratio), increased apoptosis, and collagen-related protein expression associated with mesenchymal transition. Chronic D-4F pretreatment of Tsk(-/+) mice attenuated many of these adverse effects. The findings demonstrate that abnormal fibrillin-1 expression and chronic oxidative stress mediate endothelial mesenchymal transition in Tsk(-/+) mice. This mesenchymal transition may contribute to the reduction in angiogenesis that is known to occur in this model of SSc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21160034      PMCID: PMC3063974          DOI: 10.1152/ajpcell.00123.2010

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  16 in total

1.  Fluorescent Indicators for Imaging Nitric Oxide Production.

Authors: 
Journal:  Angew Chem Int Ed Engl       Date:  1999-11-02       Impact factor: 15.336

2.  Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide.

Authors:  G Datta; M Chaddha; S Hama; M Navab; A M Fogelman; D W Garber; V K Mishra; R M Epand; R F Epand; S Lund-Katz; M C Phillips; J P Segrest; G M Anantharamaiah
Journal:  J Lipid Res       Date:  2001-07       Impact factor: 5.922

Review 3.  Biomarkers for epithelial-mesenchymal transitions.

Authors:  Michael Zeisberg; Eric G Neilson
Journal:  J Clin Invest       Date:  2009-06-01       Impact factor: 14.808

4.  Chronic NOS inhibition actuates endothelial-mesenchymal transformation.

Authors:  Edmond O'Riordan; Natalia Mendelev; Susann Patschan; Daniel Patschan; Jonathan Eskander; Leona Cohen-Gould; Praveen Chander; Michael S Goligorsky
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-09-08       Impact factor: 4.733

Review 5.  Lipid peroxidation and biogenic aldehydes: from the identification of 4-hydroxynonenal to further achievements in biopathology.

Authors:  M Comporti
Journal:  Free Radic Res       Date:  1998-06

6.  Effects of D-4F on vasodilation, oxidative stress, angiostatin, myocardial inflammation, and angiogenic potential in tight-skin mice.

Authors:  Dorothee Weihrauch; Hao Xu; Yang Shi; Jingli Wang; Jennifer Brien; Deron W Jones; Sushma Kaul; Richard A Komorowski; Mary Ellen Csuka; Keith T Oldham; Kirkwood A Pritchard
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-05-11       Impact factor: 4.733

7.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis.

Authors:  Elisabeth M Zeisberg; Oleg Tarnavski; Michael Zeisberg; Adam L Dorfman; Julie R McMullen; Erika Gustafsson; Anil Chandraker; Xueli Yuan; William T Pu; Anita B Roberts; Eric G Neilson; Mohamed H Sayegh; Seigo Izumo; Raghu Kalluri
Journal:  Nat Med       Date:  2007-07-29       Impact factor: 53.440

8.  Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II.

Authors:  Rhian M Touyz; Xin Chen; Fatiha Tabet; Guoying Yao; Gang He; Mark T Quinn; Patrick J Pagano; Ernesto L Schiffrin
Journal:  Circ Res       Date:  2002-06-14       Impact factor: 17.367

9.  Isolation and ultrastructural analysis of microfibrillar structures from foetal bovine elastic tissues. Relative abundance and supramolecular architecture of type VI collagen assemblies and fibrillin.

Authors:  C M Kielty; C Cummings; S P Whittaker; C A Shuttleworth; M E Grant
Journal:  J Cell Sci       Date:  1991-08       Impact factor: 5.285

10.  Identification and characterization of a fibroblast marker: FSP1.

Authors:  F Strutz; H Okada; C W Lo; T Danoff; R L Carone; J E Tomaszewski; E G Neilson
Journal:  J Cell Biol       Date:  1995-07       Impact factor: 10.539

View more
  17 in total

Review 1.  A vascular mechanistic approach to understanding Raynaud phenomenon.

Authors:  Nicholas A Flavahan
Journal:  Nat Rev Rheumatol       Date:  2014-12-23       Impact factor: 20.543

2.  Transient repetitive exposure to low level light therapy enhances collateral blood vessel growth in the ischemic hindlimb of the tight skin mouse.

Authors:  Maria Zaidi; John G Krolikowki; Deron W Jones; Kirkwood A Pritchard; Janine Struve; Sandhya D Nandedkar; Nicole L Lohr; Paul S Pagel; Dorothée Weihrauch
Journal:  Photochem Photobiol       Date:  2013-01-07       Impact factor: 3.421

Review 3.  Apolipoprotein-AI and AIBP synergetic anti-inflammation as vascular diseases therapy: the new perspective.

Authors:  Ampadu O Jackson; Ganiyu A Rahman; Shiyin Long
Journal:  Mol Cell Biochem       Date:  2021-04-03       Impact factor: 3.396

4.  A system out of breath: how hypoxia possibly contributes to the pathogenesis of systemic sclerosis.

Authors:  T W van Hal; L van Bon; T R D J Radstake
Journal:  Int J Rheumatol       Date:  2011-11-20

Review 5.  Endothelial-to-mesenchymal transition in systemic sclerosis.

Authors:  P Cipriani; R Giacomelli; P Di Benedetto; P Ruscitti; O Berardicurti; M Vomero; L Navarini; V Dolo
Journal:  Clin Exp Immunol       Date:  2021-04-18       Impact factor: 5.732

Review 6.  Updates on morphea: role of vascular injury and advances in treatment.

Authors:  Julio C Sartori-Valinotti; Megha M Tollefson; Ann M Reed
Journal:  Autoimmune Dis       Date:  2013-11-12

7.  Angiotensin II induces skin fibrosis: a novel mouse model of dermal fibrosis.

Authors:  Lukasz Stawski; Rong Han; Andreea M Bujor; Maria Trojanowska
Journal:  Arthritis Res Ther       Date:  2012-08-22       Impact factor: 5.156

8.  4F decreases IRF5 expression and activation in hearts of tight skin mice.

Authors:  Hao Xu; John G Krolikowski; Deron W Jones; Zhi-Dong Ge; Paul S Pagel; Kirkwood A Pritchard; Dorothée Weihrauch
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

9.  Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide.

Authors:  Marilisa Villano; Annalisa Borghini; Mirko Manetti; Erica Gabbrielli; Antonella Rossi; Piersante Sestini; Anna Milia; Francesca Nacci; Serena Guiducci; Marco Matucci-Cerinic; Lidia Ibba-Manneschi; Elisabetta Weber
Journal:  Arthritis Res Ther       Date:  2013-08-20       Impact factor: 5.156

10.  Constitutively active Notch1 signaling promotes endothelial‑mesenchymal transition in a conditional transgenic mouse model.

Authors:  Ju Liu; Fengyun Dong; James Jeong; Takahiro Masuda; Corrinne G Lobe
Journal:  Int J Mol Med       Date:  2014-06-24       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.